2Goodnough,LT.Pharmacologic alternatives to blood[A].In:Duguid J,Goodnough LT,Desmond MJ ed.Transfusion medicine in practice[M].10rd ed.London:Martin Dunitz Ltd,2002,199-213
3Hutchinson AB,Ferguson D,Graham ID,et al.Utilization of technologies to reduce allogeneic blood transfusion in the United States[J].Transfusion Med,2001,11(2):79
4Goodnough LT,Rudick S,Price TH,et al.Incresed collection of autologous blood preoperativeily with recombinant human erythropoietin therapy[J].N Engl J Med 1989;321(17):1163
5Goodnough LT,Price TH,Rudnick S,et al.Preoperative red blood cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy[J].Transfusion,1992,32 (5):441
6Feagan BG,Wong CJ,Lau CY,et al.Transfusion practice in elective orthopaedic surgery[J].Transfusion Med,2001,11 (2):87
7Feagan BG,Wong CJ,Kirkley A,et al.Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthoplasty[J].Ann Intern Med,2000,133 (11):845
8Savonije JH,van Groeningen CJ,Wormhoudt LW,et al.Early intervention with epoetin alfa during platinum-based chemotherapy:an analysis of the results of a multicenter,randomized,controlled trial based on initial hemoglobin level[J].Oncologist,2006,11(2):206
9Corwin HL.The role of erythropoietin therapy in the critically ill[J].Transfus Med Rev,2006,20(1):27
10Price TH,Goodnough LT,Vogler W,et al.The effect of recombinant erythropoietin administration on the efficacy of autologous blood donation in patinents with low hematocrits[J].Transfusion,1996,36(1):29
